20 May 2013
Keywords: EMA, CHMP drug opinions, Eliquis, Cinzyre, Vectibix, Herception, Lucentis, Remicade, Revatio
Article | 21 March 2011
The European Medicines Agency’s advisory panel, the Committee for Medicinal Products for Human Use (CHMP), has issued a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.